About International
Medical Instruments Inc.

Corporate Profile & Structure

"IMI Healing Technologies is the developer and manufacturer of the superior efficacy LEP2000™ Photonic and Laser Therapy System and its modules used for pain treatment"
Dr. Natasha Salansky,
founder
LEP2000™
Photonic and Laser Therapy System
for Laser Therapy
Therapeutic Cold Lasers for Professionals
xyxyxy  

IMIHT is the developer and manufacturer of the Laser Therapy System

IMI Healing Technologies’ prime mission is to bring the recognition and use by medical communities in North America and around the Globe of its LEP2000™ Photonic and Laser Therapy System, and to offer high-efficacy therapeutic devices based on scientifically and clinically proven healing properties of multi-modality photonic and laser therapy approaches.

IMIHT is the world leader in therapeutic efficacy and versatility of the multi-modality LEP2000™ Photonic and Laser Therapy System and its modules

IMI Healing Technologies is the developer and manufacturer of the superior efficacy LEP2000™ Photonic and Laser Therapy System and its modules used for pain treatment, nerve regeneration, wound and tissue healing. IMI Healing Technologies (IMIHT) carries on research and development, and attends to the manufacture, distribution and servicing of LEP2000™ therapeutic lasers and cluster modules of light emitting diodes that feature high efficacy for a broad variety of medical applications.
HOME
ABOUT US
LASER THERAPY
CLINICAL EVIDENCE
CLINICAL COMMENTS
TESTIMONIALS
EDUCATION & TRAINING
SALES
CUSTOMER SERVICES
IMI Healing Technologies (IMIHT) is the operating name for a Canadian corporation - International Medical Instruments Inc. (IMI Inc.). IMI Inc. was founded in 1984 by a Canadian scientist Dr. Norman Salansky, PhD, and operated initially under the name International Medical Machines Inc. IMIHT is the world leader in therapeutic efficacy and versatility of the multi-modality LEP2000™ Photonic and Laser Therapy System and its modules (see clinical evidence and laser therapy advancements).

The development of the above technology is predicated by the interdisciplinary nature of photon and tissue interaction phenomena. It is therefore necessary to combine the expertise of proficient medical authorities in the field of pain management, physical medicine and rehabilitation, sports medicine, rheumatology, neurology, immunology, etc., and specialists in photon sources (lasers, LEDs, SLDs and other light sources) to ensure control of the parameters governing software development in order to obtain required 3D photon distributions in the tissue that will activate specific healing mechanisms.

Based on the above considerations, the corporate structure includes in-house expertise of the core group together with external medical expertise (see the diagram below).

Synergy of Interdisciplinary Interactive Approach

1+1 = ∞

∞ - infinite gain in development of a scientifically sound and clinically proven technology
Synergy of Interdisciplinary Interactive Approach
The core of the corporation consists of scientists and engineers in the field of optical sources (lasers, LEDs, clusters, etc.) and software and hardware specialists capable of providing control for the sources of output parameters for the optimization of different therapeutic applications. They also have expertise in Monte-Carlo and Neural Network software to calculate 3D distribution of photons in the tissue, as well as expertise in hardware design and construction of biomedical devices and regulatory issues.

A medical advisory committee was set up with a mandate among others to consult the core group in different areas of medicine such as pain management, sports medicine, rheumatology, neurology, physical medicine and rehabilitation, immunology, and other specialties.

As a result of an interactive collaborative effort with these specialists the core group developed the main concepts for the design of an effective LEP2000™ Photonic and Laser Therapy System family of therapeutic devices.

The basic concepts are:
  • Most painful diseases (acute, sub-acute or chronic) have underlying pathological conditions of biotissues. Examples of these pathological conditions could be: depletion of cellular energy ATP, or tissue ischemia, acute or chronic inflammation, nerve damage, impairment of microcirculation that can lead to ATP depletion, and others.
  • Many pathological conditions of biotissues could be improved or reversed to normal state using specific sets of optical parameters of monochromatic light emission called Therapeutic Optical Windows (TOWs) that can induce specific healing mechanisms in biotissue (see 10 basic mechanisms).
  • In order to increase efficacy, TOWs that are used in LEP2000™ technology were optimized for greater immediate and sustainable pain relief for different pathological conditions, stages of disease (acute, sub-acute, or chronic), and different patients (weak, elderly, athletes, etc.).
  • TOWs include delivery of required three-dimensional (3D) photon distributions to the injured pathological tissue. If a TOW has correct optical parameters to treat a tissue’s particular pathological condition but a required 3D photon distribution is not delivered, there would be no or low efficacy.
  • Usually pain is reduced or eliminated while underlying pathological conditions are improved or healed with LEPT LEP2000™.
  • One or several specific TOWs are required to improve or reverse to normal state a tissue’s particular pathological condition.
  • These TOWs are usually applied in sequence to pathological tissues in accordance with Drs. Salansky Protocols in order to treat effectively a particular painful disease using LEP2000™ Photonic Therapy System as a multi-modality photonic and laser therapy.
  • Several TOWs are applied to the pathological tissue in order to treat underlying pathologies and increase therapeutic efficacy.
Since 1990, our company has operated clinical facilities where highly trained medical personnel have successfully treated thousands of patients using the LEP2000™ Photonic and Laser Therapy System in accordance with Drs. Salansky Clinical Protocols. The above concepts were implemented in the technology using the feedback from the clinics for the optimization and final tuning of Drs. Salansky Protocols. See a diagram for the stages of Drs. Salansky Protocol Development.

Over the last 25 Years, the IMIHT scientific team, in close collaboration with university scientists and medical doctors, has conducted research on key aspects of the healing mechanisms that could be inducedin biotissue by monochromatic light. Special emphasis of this research was made on so-called dosimetry of photon-biotissue interactions - an in-depth investigation of optical parameters that are required to induce particular healing mechanisms and therapeutic effects.

The main goal of IMIHT research was to perfect the therapeutic efficacy and versatility of its medical devices. Leading IMIHT scientists Dr. Norman Salansky, PhD, and Dr. Natasha Salansky PhD, DAc, developed clinical protocols for effective pain treatment, nerve regeneration, and tissue healing using the LEP2000™ system. This research was supported by Canadian Government grants with the first grant received from the National Research Council of Canada in 1985 (see grants).

For over two decades, high therapeutic efficacy of LEP2000™ Photonic and Laser Therapy System has been identified in numerous clinical studies including controlled and double blind clinical trials (see clinical evidence).

The company obtained Health Canada and FDA approvals and its intellectual property is covered by comprehensive patents.

1px 1px 1px 1px